Humar A, Johnson E M, Gillingham K J, Sutherland D E, Payne W D, Dunn D L, Wrenshall L E, Najarian J S, Gruessner R W, Matas A J
Department of Surgery, University of Minnesota, Minneapolis 55455, USA.
Transplantation. 1998 Jan 27;65(2):229-34. doi: 10.1097/00007890-199801270-00015.
We reviewed the incidence of and risk factors for venous thromboembolic complications in our population of kidney (KTx) and simultaneous kidney-pancreas transplant (SPK) recipients.
Information was collected retrospectively from a database on 1833 KTx and 276 SPK recipients who underwent transplant surgery between January 1985 and August 1995.
The incidence of deep venous thrombosis (DVT) was 6.2% (n= 132), with significantly higher rates after SPK (18.1%) vs. KTx (4.5%) (P < 0.001). The number of DVT episodes was highest in the first month; 17.5% occurred during this time. For KTx recipients, early thrombotic events were more common on the side of the graft (P=0.03); however, after 1 month, no correlation existed between the side of the graft and the side of DVT. For SPK recipients, DVT tended to be more common on the side of the pancreas (57%) vs. the kidney (43%) (P=0.10). By multivariate analysis, risk factors for DVT were: age > 40 years (odds ratio [OR]=2.2, P < 0.001), diabetes mellitus (DM) (OR=2.0, P=0.002), previous DVT (OR=4.4, P=0.001), and SPK transplant (OR=2.8, P < 0.001). Pulmonary embolus (PE) was identified in 44 recipients (incidence, 2.1%) and was fatal in 13 (30%). The incidence was significantly higher in SPK (4.71%) vs. KTx recipients (1.69%) (P < 0.01). The risk of death from PE was 0.5% in KTx recipients and 1.37% in SPK recipients (P=0.08). Risk factors for PE included DM (OR=2.6, P=0.005) and recent DVT (OR=8.9, P=0.0001).
Based on risk and extrapolating from the general surgical literature, our recommendations for prophylaxis against DVT are use of graduated compression stockings for all recipients and, in addition, low-dose heparin for moderate and high-risk recipients (previous DVT, SPK, age > 40 years, DM).
我们回顾了我们的肾移植(KTx)和同期肾胰联合移植(SPK)受者人群中静脉血栓栓塞并发症的发生率及危险因素。
回顾性收集了1985年1月至1995年8月期间接受移植手术的1833例KTx受者和276例SPK受者的数据库信息。
深静脉血栓形成(DVT)的发生率为6.2%(n = 132),SPK受者(18.1%)的发生率显著高于KTx受者(4.5%)(P < 0.001)。DVT发作次数在第一个月最高;17.5%发生在此期间。对于KTx受者,早期血栓形成事件在移植侧更常见(P = 0.03);然而,1个月后,移植侧与DVT侧之间不存在相关性。对于SPK受者,DVT在胰腺侧(57%)比肾侧(43%)更常见(P = 0.10)。通过多因素分析,DVT的危险因素为:年龄>40岁(比值比[OR]=2.2,P < 0.001)、糖尿病(DM)(OR=2.0,P = 0.002)、既往DVT(OR=4.4,P = 0.001)和SPK移植(OR=2.8,P < 0.001)。44例受者发生肺栓塞(PE)(发生率为2.1%),其中13例(30%)死亡。SPK受者(4.71%)的发生率显著高于KTx受者(1.69%)(P < 0.01)。KTx受者因PE死亡的风险为0.5%,SPK受者为1.37%(P = 0.08)。PE的危险因素包括DM(OR=2.6,P = 0.005)和近期DVT(OR=8.9,P = 0.0001)。
基于风险并从普通外科文献推断,我们预防DVT的建议是所有受者使用分级压力袜,此外,中高危受者(既往DVT、SPK、年龄>40岁、DM)使用低剂量肝素。